ursodeoxycholic acid has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; He, Z; Li, S; Liu, S; Ma, Y; Wang, W; Wang, Y; Xiao, J; Yang, H; Yang, S; Zhang, S | 1 |
| Hatsuse, K; Kawarabayashi, N; Kinoshita, M; Miyazaki, H; Nishiyama, K; Ono, S; Saitoh, D; Seki, S; Takigawa, T; Yamamoto, J | 1 |
2 other study(ies) available for ursodeoxycholic acid and Escherichia coli Infections
| Article | Year |
|---|---|
Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Caco-2 Cells; Cattle; Colitis; Diarrhea; Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Homeostasis; Humans; Mice; Sepsis; Ursodeoxycholic Acid | 2022 |
Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice.
Topics: Animals; Cells, Cultured; Concanavalin A; Escherichia coli; Escherichia coli Infections; Hepatitis, Animal; Hepatocytes; Immunologic Factors; Interleukin-18; Kupffer Cells; Lipopolysaccharides; Liver; Lymphocytes; Mice; Mice, Inbred C57BL; Receptors, Glucocorticoid; Shock, Septic; Transcription, Genetic; Ursodeoxycholic Acid | 2013 |